CLINICAL_TRIALS
trial_result
· 2015-06-01
Clinical Trial Update: Tracking Resistance to Artemisinin (TRAC) [Phase 4]
Summary
The Phase 4 TRAC trial tracking resistance to artemisinin in Plasmodium falciparum malaria has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oxford | Conditions: Falciparum Malaria | Phase 4 | Status: COMPLETED